| [1] |
Wang TT,Xu GX.Advancement on study of pharmacological action and clinical application of cinobufotalin[J].Guo Ji Yan Ke Za Zhi,2009，9(7):1330-3.[王婷婷，徐国兴.华蟾素的药理作用研究及临床应用进展[J].国际眼科杂志,2009,9(7):1330-3.]
|
| [2] |
Gong ZP,Chen T.Deng LR,et al.Clinical application progress of cinobufagin to cancer pain relief [J].XianDai Yao Wu Yu Lin Chuang,2010，25(4):268-71.[巩仔鹏，陈涛，邓李蓉，等.华蟾素治疗癌痛的临床应用研究进展[J].现代药物与临床，2010，25(4):268-71.]
|
| [3] |
Zhang ZY,Zhang KH,Wang CW,et al.Cytotoxocity of cinobufotalin on three digestive tract tumor cells in vitro[J].Zhong Yao Yao Li Yu Lin Chuang,1999，15(5):28-9.[张振玉，张昆和，王崇文，等.华蟾素对三种消化系肿瘤细胞杀伤机制研究[J].中药药理与临床，1999，15(5):28-9.]
|
| [4] |
Masuda Y,Kawazoe N,Nakajo S,et al.Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells[J].Leuk Res，1995，19(8):549-56.
|
| [5] |
Sheng XS,Xu LJ.Effects of cinobufacini on apoptosis and expression of Caspase-3 in leukemia cells[J].ShiYong Zhong Liu Za Zhi，2007，22(1):32-5.[盛秀胜，徐玲娟.华蟾素诱导人红白血病细胞K562凋亡及对Caspase-3表达的影响[J].实用肿瘤杂志，2007，22(1):32-5.]
|
| [6] |
Zuo XD,Cui YA,Qin SK,et al.Effect of cinobufacini on tumor cell cycle and expression of bcl-2 protein[J].Xian Dai Zhong Xi Yi Jie Je Za Zhi,2003，12(6):567-8.[左小东，崔永安，秦叔奎，等.华蟾素对肿瘤细胞周期及bcl-2蛋白表达的影响[J].现代中西医结合杂志，2003，12(6):567-8.]
|
| [7] |
Wang NY,Li SY,Zhao W,et al.Study the effect of antiangiogenesis of ansenic trioxide in combination withcinobufacin on chick embryo chorioallantoic membrane （CAM）[J].Lin Chuang Zhong Liu Xue Za Zhi,2006，11(7):494-6.[王南瑶，李苏宜，赵伟，等.华蟾素联合三氧化二砷抑制鸡胚尿囊膜血管生成的实验研究[J].临床肿瘤学杂志，2006，11 (7):494-6.]
|
| [8] |
Reis e Sousa C.Dendritic cells as sensors of infection [J].Immunity，2001，14(5):495-8.
|
| [9] |
Banchereau J,Steinman RM.Dendritic cells and the control of immunity[J].Nature,1998,392(6673):245-52.
|
| [10] |
Ovali E,Dikmen T,Sonmez M,et al.Active immunotherapy for cancer patients using tumor lysate pulseddendritic cell vaccine:a safety study [J].J Exp Clin Cancer Res,2007,26(2):209-14.
|
| [11] |
Grayson MH,Holtzman MJ.Emerging role of dendritic cells in respiratory viral infection [J].J Mol Med(Berl)，2007，85(10):1057-68.
|
| [12] |
Jung S.Good,bad and beautiful--the role of dendritic cells in autoimmunity[J].Autoimmne Rev,2004,3(1):54-60.
|
| [13] |
Radhakrishnan S,Celis E，Pease LR.B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cells [J].Proc Natl Acad Sci U S A,2005,102(32):11438-43.
|
| [14] |
Wang YF,Sun SG,He GH,et al.In vitro induction and expansion of dendritic cells from rat bone marrow andtheir characterization[J].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi,2005，21(1):76-8.[王云甫，孙圣刚，何国厚，等.体外诱导扩增大鼠树突状细胞及其特性鉴定[J].细胞与分子免疫学杂志，2005，21(1):76-8.]
|
| [15] |
Su Y,Wang JL,Chen FQ,et al.A method to amplify and purify dendritic cells from rat bone marrow in vitro [J].Zhongguo Zu Zhi Gong Cheng Xue Yan Jiu Yu Lin Chuang Kang Fu,2007,11(50):10049-52.[苏钰，王锦玲，陈福权，等.建立大鼠骨髓源性树突状细胞体外扩增及纯化的方法[J].中国组织工程学研究与临床康复，2007，11(50):10049-52.]
|
| [16] |
Wei XL,Wang XY,Tang W.Effect of cinobufotalin on the dendritic cells derivedfrom peripheral blood of healthadults[J].Nantong Da Xue Xue Bao (Yi Xue Ban)，2007，27(2):98-100.[危晓莉，汪晓莺，汤伟.华蟾素对正常人外周血来源树突状细胞的影响[J].南通大学学报（医学版），2007，27(2):98-100.]
|
| [17] |
Wei XL,Wang XY,Tang W,et al.Effect of cinobufotalin on the dendritic cells derived fromperipheral blood ofpatients with chronic hepatitis B[J].Zhong Yao Yao Li Yu Lin Chuang,2007,23(4):54-6.[危晓莉,汪晓莺,汤伟,等.华蟾素对慢性乙型肝炎患者外周血来源树突状细胞的影响[J].中药药理与临床,2007,23(4):54-6.]
|
| [18] |
Wang Y,Nv HY,Guo J,et al.Relationship between the inhibition of tumor growth and the expression of the IL-2,IFN-γ and IL-10 in spleen cells and tumor tissue of renal carcinoma in nude mice after radiotherapy[J].Di SiJun Yi Da Xue Xue Bao,2009,30(20):2122-4.[王瑶,吕海燕,郭佳,等.放射治疗荷肾癌小鼠肿瘤生长抑制与脾细胞及肿瘤组织IL-2,IFN-γ和IL-10的关系[J].第四军医大学学报，2009,30(20):2122-4.]
|
| [19] |
Abrams SI.Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response[J].Front Biosci,2005,10:809-21.
|
| [20] |
Zou W.Immunosuppressive networks in the tumorenvironment and their therapeutic relevance[J].Nat RevCancer,2005,5(4):263-74.
|
| [21] |
Marotta G,Frassoldati A,Zinzani P,et al.Role of interferon-alphaadministration after 2-deoxy coformycin inthe treatment of hairy cell leukemia patients[J].Eur J Haematol,2006,77(2):109-13.
|
| [22] |
Foley JE,Mariotti J,Ryan K,et al.Th2 cell therapy of established acute graft-versus-hostdisease requiresIL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells[J].Biol Blood MarrowTransplant,2008,14(9):959-72.
|
| [23] |
Zhao XM,Chen XM,Yang ZY,et al.Effect of cinosufotalin on the level of IL-2 and LAK cell activity[J].Zhong Yao Yao Li Yu Lin Chuang,1999,15(6):33-5.[赵兴梅,陈晓明,杨祖贻,等.华蟾素注射液对人IL-2水平及LAK细胞活性的影响[J].中药药理与临床,1999,15(6):33-5.]
|
| [24] |
Liu XS,Liu KJ,Yang YJ.Effects of cinobufacini on the growth of Hela cell and IL-2 production of murinespleen lymphocytes[J].Mian Yi Xue Za Zhi,2005,21(3):132-5.[刘祥胜,刘开俊,杨业金.华蟾素对HELA细胞生长和小鼠脾淋巴细胞分泌IL-2的影响[J].免疫学杂志，2005，21(3):132-5.]
|
下载:
